atai Life Sciences Announces $50 Million Private Placement Financing
(NasdaqGM:ATAI), NEW YORK and AMSTERDAM, July 01, 2025 (GLOBE NEWSWIRE) — atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company on a mission to develop highly effective mental health treatments to transform patient outcomes, today announced it had entered into subscription agreements relating to the purchase of 18,264,840 ordinary shares of atai with a […]